VCU Massey and Sanford Burnham Prebys Complete First Funding Cycle of Cancer Drug Discovery Collaboration

The VCU Massey Comprehensive Cancer Center has completed the first funding cycle of its collaborative program with the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, California. The initiative is part of Massey’s Molecules to Medicine (M2M) framework, which focuses on advancing drug discovery efforts for cancer therapeutics. This partnership aims to accelerate the development of innovative treatments by combining resources and expertise from both institutions.

The collaboration leverages SBP’s capabilities in drug discovery and Massey’s research strengths in cancer biology to identify and develop potential therapeutic compounds. The program represents a significant step in fostering interdisciplinary approaches to address complex challenges in cancer treatment. Researchers involved have worked on identifying promising molecular targets and exploring new strategies for intervention during this initial funding cycle. Further details about specific outcomes or discoveries from the collaboration were not disclosed at this time.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI